Evidence map›Paper›PMID 20375690›Full record

Trial reportThe American journal of the medical sciences2010

High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data.

Barry M Wall, Regina M Hardison, Mark E Molitch, Oscar C Marroquin, Janet B McGill, Phyllis A August, BARI 2D Study Group

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of the medical sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00006305 (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes), which is not on this map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00006305 phase3completednot on this map

Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes

TypeinterventionalSponsorUniversity of PittsburghRan2000 to 2009Enrolled2,368ConditionsCoronary Disease, Cardiovascular Diseases, Heart Diseases, Insulin ResistanceArmsAngioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions, Coronary Artery Bypass, Biguanides, thiazolidinediones, Insulin, sulfonylurea, ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Barry M WallVeterans Affairs Medical Center, University of Tennessee Health Science Center, Memphis, Tennessee 38104, USA. Barry.Wall@med.va.gov
Regina M Hardison
Mark E Molitch
Oscar C Marroquin
Janet B McGill
Phyllis A August
BARI 2D Study Group
Cornell University · USUniversity of Pittsburgh · USUniversity of Pittsburgh Medical Center · USUniversity of Tennessee Health Science Center · US

Funding

BARI II:Foreign RecruitmentU01HL061744 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELSEY, SHERYL F · 2000 to 2009
$55.4M
BARI II - FIBRINOLYSIS AND COAGULATION COREU01HL063804 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI SOBEL, BURTON E · 2000 to 2006
$3.8M
ECONOMIC OUTCOMES OF TREATMENT STRATEGIES IN BAR1-2U01HL061748 · NHLBI · STANFORD UNIVERSITY · PI HLATKY, MARK A. · 2000 to 2006
$2.6M
BARI II GRANT PROPOSAL FOR ECG CORE LABORATORYU01HL061746 · NHLBI · SAINT LOUIS UNIVERSITY · PI CHAITMAN, BERNARD R · 2000 to 2008
$1.6M
NHLBI NIH HHS U01 HL061744NHLBI NIH HHS U01 HL061746NHLBI NIH HHS U01 HL061748NHLBI NIH HHS U01 HL063804
6 · The paper itself

Abstract

backgroundWe describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality.

methodsStudy participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated.

resultsTwo thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR > or =60 mL/min/1.73 m with either microalbuminuria ( >30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR <60 mL/min/1.73 m; 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR.

conclusionKidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.

Indexed as

AgedAged, 80 and overAlbuminuriaCoronary Artery BypassCoronary Artery DiseaseDiabetes Mellitus, Type 2FemaleHumansMaleRenal Insufficiency

Identifiers

PMID20375690
PMCPMC4312489
OpenAlexW1969478296

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.